Health Canada (2017) Quality (chemistry and manufacturing) guidance: new drug submissions

(NDSs) and abbreviated new drug submissions (ANDSs). https://www.canada.ca/content/dam/

hc-sc/documents/services/drugs-health-products/drug-products/applications-submissions/guid

ance-documents/chemical-entity-products-quality/guidance-document-quality-chemistry-

manufacturing-guidance-new-drug-submissions-ndss-abbreviated-new-drug-submissions.pdf.

Accessed 15 Apr 2019

Houson IE (2011) Process understanding: for scale-up and manufacture of active ingredients. John

Wiley & Sons

Hunter AC, Elsom J, Wibroe PP, Moghimi SM (2012) Polymeric particulate technologies for oral

drug delivery and targeting: a pathophysiological perspective. Nanomedicine 8:S5–S20

ICH Harmonised Tripartite Guideline (2005) Quality risk management Q9 2005 [cited 2022

February 22]; Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/

Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf. Accessed 22 Feb 2022

ICH Harmonised Tripartite Guideline (2008) Pharmaceutical quality system Q10. https://www.ich.

org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_

Guideline.pdf. Accessed 10 May 2019

ICH Harmonised Tripartite Guideline (2009) Pharmaceutical development Q8 (R2). https://www.

ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_

Guideline.pdf. Accessed 10 May 2019

Ishak RAH, Mostafa NM, Kamel AO (2017) Stealth lipid polymer hybrid nanoparticles loaded with

rutin for effective brain delivery–comparative study with the gold standard (Tween 80):

optimization, characterization and biodistribution. Drug Deliv 24(1):1874–1890

Ismail R, Sovány T, Gácsi A, Ambrus R, Katona G, Imre N et al (2019) Synthesis and statistical

optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating GLP1 analog

designed for oral delivery. Pharm Res 36(7):1–16

Jain A, Jain A, Garg NK, Tyagi RK, Singh B, Katare OP et al (2015a) Surface engineered polymeric

nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved

understanding of brain cancer. Acta Biomater 24:140–151

Jain S, Patel N, Madan P, Lin S (2015b) Quality by design approach for formulation, evaluation and

statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev

Technol 20(4):473–489

Jain A, Kaur R, Beg S, Kushwah V, Jain S, Singh B (2018) Novel cationic supersaturable

nanomicellar systems of raloxifene hydrochloride with enhanced biopharmaceutical attributes.

Drug Deliv Translat Res 8(3):670–692

Jose C, Amra K, Bhavsar C, Momin M, Omri A (2018) Polymeric lipid hybrid nanoparticles:

properties and therapeutic applications. Crit Rev Ther Drug Carrier Syst 35(6):555–588

Junghanns J, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int

J Nanomedicine 3(3):295–309

Kanwar N, Sinha VR (2019) In situ forming depots as sustained release drug delivery systems. Crit

Rev Ther Drug Carrier Syst 36:93–136

Karakucuk A, Celebi N, Teksin ZS (2016) Preparation of ritonavir nanosuspensions by

microfluidization using polymeric stabilizers: I. A design of experiment approach. Eur J

Pharm Biopharm 95:111–121

Karunanidhi P, Puran Lal S, Singh S (2018) Optimization of processing parameters for the

development of Ficus religiosa L. extract loaded solid lipid nanoparticles using central compos-

ite design and evaluation of antidiabetic efficacy. J Drug Deliv Sci Technol 43:94–102

Khalil RM, Abdelbary A, Kocova El-Arini S, Basha M, El-Hashemy HA (2018) Evaluation of

bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and

ex vivo optimization. J Liposome Res 29:1–12

Khurana RK, Bansal AK, Beg S, Burrow AJ, Katare OP, Singh KK et al (2017) Enhancing

biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers

of mangiferin: systematic development, characterization and evaluation. Int J Pharm

518(1–2):289–306

346

B. Singh et al.